Bristol-Myers Squibb Co. recalled 60 million tablets of the blood pressure medication Avalide (irbesartan-hydrochlorothiazide) in the United States and Puerto Rico.
According to the company, it took the action on behalf of the Bristol-Myers Squibb/Sanofi-Synthelabo partnership because of a potential variability in levels of the less-soluble form of the active ingredient, irbesartan, which could result in slower dissolution. The recalled tablets contain 300 mg of irbesartan and 25 mg of hydrochlorothiazide.
Sixty-two lots, or 60 million tablets, manufactured before November 2009 at its Puerto Rico plant were affected by the recall.
Click here to read entire article